Tenofovir versus entecavir on decreasing risk of HBV-related hepatocellular carcinoma recurrence after liver transplantation

Tenofovir versus entecavir on decreasing risk of HBV-related hepatocellular carcinoma recurrence after liver transplantation

Abstract Background Recent studies have proved that tenofovir disoproxil fumarate (TDF) is associated with a lower risk of hepatocellular carcinoma (HCC) occurrence in chronic hepatitis B (CHB) patients and HCC recurrence in patients who underwent hepatectomy when compared to ETV. However, it is unc...

Full description

Bibliographic Details
Main Authors: Jianming Yang, Yewu Chen, Haobin Sun, Xijian Zhang, Jianfeng Wang, Zhixing Liang, Binsheng Fu, Tong Zhang, Shuhong Yi, Yinan Deng, Yang Yang
Format: Article
Language:English
Published: BMC 2023-01-01
Series:Infectious Agents and Cancer
Subjects:
Tenofovir disoproxil fumarate
Entecavir
Nucleos(t)ide analogues
Hepatocellular carcinoma
Recurrence
Liver transplantation
Online Access:https://doi.org/10.1186/s13027-022-00478-4

Internet

https://doi.org/10.1186/s13027-022-00478-4

Similar Items